Metabolon has signed a multi-year research alliance with Japan based Takeda to develop new therapeutic targets and biomarkers. Under the collaboration, Metabolon will apply its platform to discover and validate targets, and identify ...
Tags: Drug Discovery Alliance, Takeda's R&D programs, metabolomic profiling